CLINICAL_TRIALS
trial_result
· 2013-05-20
Clinical Trial Update: Exemestane in Preventing Cancer in Postmenopausal Women at Increased Risk of Developing Breast Cancer [Phase 3]
Summary
Phase 3 clinical trial update on exemestane for breast cancer prevention in postmenopausal women at elevated risk.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: NCIC Clinical Trials Group | Conditions: Breast Cancer | Phase 3 | Status: COMPLETED | Results posted: 2013-05-20